Charles River Laboratories International, Inc. (CRL) stock
CRLNYSEServices-Commercial Physical & Biological ResearchFiscal year ends December 27
Financials through Q2 FY2026, quarter ended Jun 27, 2026Last filing: 10-Q on Nov 4, 2026Score 6/30225% above fair value
$332.16−3.36 (-1.00%)
Close on Nov 17, 2026Market cap $15.86BP/E –Yield –
Charles River Laboratories International r&d expenses
Research and development expenses are spending on new products and technology.
No r&d expenses figures for Charles River Laboratories International
Charles River Laboratories International has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?